Poly (ADP-ribose) polymerase-1 (PARP-1) as immune regulator.

Endocr Metab Immune Disord Drug Targets 2011 Dec;11(4):326-33

ENEA (Italian Agency for New Technologies, Energy and Sustainable Economic Development), Laboratory of Radiation Biology and Biomedicine, Rome, Italy.

Poly(ADP-ribose) polymerases (PARPs) represent a family of enzymes which synthesize and bind branched polymers of ADP-ribose to acceptor proteins using NAD as a substrate. PARP-1, the prototypical representative of the family, accounts for the majority of the poly(ADP-ribose) polymer synthesis. PARP-1 functions as a DNA nick sensor and signaling molecule binding to ssDNA and dsDNA protecting cells from genomic instability. PARP-1 activity plays a relevant role in the development of inflammatory responses largely contributing to tissue damage in ischemia/reperfusion conditions, such as stroke and myocardial infarction, and in septic shock. Recently, several findings revealed a wider immunological role for PARP-1. It regulates gene transcription in several types of immune cells, including dendritic cells, macrophages and lymphocytes. PARP-1 affects the stimulatory ability of dendritic cells, T cell activation and antibody production. Inhibition of PARP-1 enzymatic activity reduces the secretion of pro-inflammatory cytokines and ameliorates autoimmune diseases in several experimental models. Our recent findings showed that PARP-1 deficiency affects T cell differentiation rendering naïve CD4 T cells prone to differentiate in regulatory T cells. All together these findings show that PARP-1 plays a pivotal role in the balance between pro-inflammatory/effector and anti-inflammatory/regulatory responses, opening new possible therapeutic perspectives.

Download full-text PDF

Source
http://dx.doi.org/10.2174/187153011797881184DOI Listing
December 2011
2 Reads

Publication Analysis

Top Keywords

parp-1
9
dendritic cells
8
findings parp-1
8
cells
6
models findings
4
tissue damage
4
contributing tissue
4
responses contributing
4
inflammatory responses
4
experimental models
4
ischemia/reperfusion conditions
4
autoimmune diseases
4
myocardial infarction
4
infarction septic
4
stroke myocardial
4
conditions stroke
4
development inflammatory
4
diseases experimental
4
damage ischemia/reperfusion
4
deficiency cell
4

Similar Publications